CS Diagnostics Corp.
CSDX
$0.10
$0.0226.16%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | ||
|---|---|---|---|---|---|
| Revenue | 11.47% | 188.75% | -98.45% | 32.08% | |
| Total Other Revenue | 83.95% | -- | -- | -- | |
| Total Revenue | 2,340.00% | 188.75% | -98.45% | 32.08% | |
| Cost of Revenue | -- | -- | -- | -- | |
| Gross Profit | 2,340.00% | 188.75% | -98.45% | 32.08% | |
| SG&A Expenses | 311.05% | 213.51% | -98.77% | -14.09% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 311.05% | 213.51% | -98.77% | -14.09% | |
| Operating Income | 407.87% | -140.00% | -95.35% | 273.26% | |
| Income Before Tax | 407.87% | -140.00% | -95.35% | 273.26% | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | 407.87% | -140.00% | -95.35% | 273.26% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | 407.87% | -140.00% | -95.35% | 273.26% | |
| EBIT | 407.87% | -140.00% | -95.35% | 273.26% | |
| EBITDA | -- | -- | -- | -- | |
| EPS Basic | 200.00% | -- | -- | 100.00% | |
| Normalized Basic EPS | -- | -- | -- | -- | |
| EPS Diluted | 200.00% | -- | -- | 100.00% | |
| Normalized Diluted EPS | -- | -- | -- | -- | |
| Average Basic Shares Outstanding | 227.78% | 5.89% | 11.47% | 23.96% | |
| Average Diluted Shares Outstanding | 227.78% | 5.89% | 11.47% | 23.96% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |